Robotic single-port (da Vinci SP) versus multiport (da Vinci Xi) for the treatment of atypical endometrial hyperplasia and endometrial cancer: A multi-institutional comparison of surgical outcomes
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.110508 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Giuseppe Cucinella und 13 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Oncology Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131, Naples, Italy; Department of Precision Medicine in Medical, …. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Endometrial Neoplasms, Endometrial Hyperplasia, Hysterectomy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The da Vinci SP robotic platform offers a novel single-port approach for minimally invasive surgery. Despite its potential, data on its safety and performance in gynecologic oncology remain limited. We aimed to compare surgical outcomes of da Vinci SP versus da Vinci Xi systems in the staging of endometrial cancer (EC). METHODS: This is a multi-institutional study. Data of consecutive patients with apparent early-stage EC or atypical endometrial hyperplasia who underwent robotic surgery between January 2023-March 2025 were collected. The primary outcome was to compare the surgical outcomes between da Vinci SP and da Vinci Xi. RESULTS: A total of 189 patients were included: 97 (51.3 %) underwent SP surgery and 92 (48.7 %) Xi. The median (range) of operative time, estimated blood loss, and postoperative hospital stay were comparable for SP and Xi groups (140 [70-296] vs. 143 [60-297] min, p = 0.66, 40 [0-250] vs. 64 [0-1300] mL, p = 0.12, 3 [1-11] vs. 3[1-10] days, p = 1). Docking time was significantly shorter in the SP group (10 [4-31] vs. 12 [7-30] min for SP and Xi, respectively, p = 0.004). Intraoperative or post-operative complications rates were comparable (p = 0.30 and p = 0.14,respectively). The patient-reported pain score was significantly lower at 12h and 24h in the Xi group (p = 0.001), while was comparable at 48h after surgery (p = 1). CONCLUSION: The da Vinci SP system appears to be non-inferior to the multiport da Vinci Xi for surgical staging of early-stage EC. Comparable perioperative outcomes support its clinical use, although patient selection criteria and long-term results require further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecologic Oncology Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131, Naples, Italy; Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, 90133…
- Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; PhD School in Biomedical Sciences, Gender Medicine, Child and Wom…
- Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCSS-Regina Elena, National Cancer Institute, Rome, Italy.
- Department of Gynecology, European Institute of Oncology, IEO, IRCCS, Milan, Italy.
- Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
- Gynecologic and Obstetric Clinic, Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
Zitieren
APA
Cucinella, G., Restaino, S., Bruno, V., Schivardi, G., Capomacchia, F. M., Capobianco, G., Di Donna, M. C., Arcieri, M., Turco, L. C., Petrillo, M., Zanagnolo, V., Vizzielli, G., Chiantera, V., & Vizza, E. (2025). Robotic single-port (da Vinci SP) versus multiport (da Vinci Xi) for the treatment of atypical endometrial hyperplasia and endometrial cancer: A multi-institutional comparison of surgical outcomes. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110508
Vancouver
Cucinella G, Restaino S, Bruno V, Schivardi G, Capomacchia FM, Capobianco G, et al. Robotic single-port (da Vinci SP) versus multiport (da Vinci Xi) for the treatment of atypical endometrial hyperplasia and endometrial cancer: A multi-institutional comparison of surgical outcomes. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110508
BibTeX
@article{Cucinella2025,
author = {Cucinella, Giuseppe and Restaino, Stefano and Bruno, Valentina and Schivardi, Gabriella and Capomacchia, Filippo Maria and Capobianco, Giampiero and Di Donna, Mariano Catello and Arcieri, Martina and Turco, Luigi Carlo and Petrillo, Marco and Zanagnolo, Vanna and Vizzielli, Giuseppe and Chiantera, Vito and Vizza, Enrico},
title = {Robotic single-port (da Vinci SP) versus multiport (da Vinci Xi) for the treatment of atypical endometrial hyperplasia and endometrial cancer: A multi-institutional comparison of surgical outcomes},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.110508}
}
EUVIMED